sb 202190 has been researched along with Colitis in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monteleone, I | 1 |
| Marafini, I | 1 |
| Dinallo, V | 1 |
| Di Fusco, D | 1 |
| Troncone, E | 1 |
| Zorzi, F | 1 |
| Laudisi, F | 1 |
| Monteleone, G | 1 |
1 other study available for sb 202190 and Colitis
| Article | Year |
|---|---|
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.
Topics: Animals; Colitis; Disease Models, Animal; Enzyme Inhibitors; Imidazoles; Interleukin-17; Intestinal | 2017 |